Response to comment to “Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer”
Loon Ong, W., Davidson, M., Cheung, P., Chung, H., Chu, W., Detsky, J., Liu, S., Morton, G., Szumacher, E., Tseng, C. L., Vesprini, D., Ravi, A., McGuffin, M., Zhang, L., Mamedov, A., Deabreu, A., Kulasingham-Poon, M. & Loblaw, A., Nov 2023, In: Radiotherapy and Oncology.188, 6 p., 109864.
Research output: Contribution to journal › Article › Research › peer-review